Helen Paterson

Summary

Publications

  1. doi request reprint A survey of New Zealand RANZCOG Fellows on their use of the levonorgestrel intrauterine device in adolescents
    Helen Paterson
    Department of Women s and Children s Health, University of Otago, Dunedin, New Zealand
    Aust N Z J Obstet Gynaecol 49:220-5. 2009
  2. doi request reprint A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents
    Helen Paterson
    Dunedin School of Medicine, Department of Women s and Children s Health, University of Otago Dunedin, New Zealand
    Contraception 79:433-8. 2009
  3. ncbi request reprint Hair loss with use of the levonorgestrel intrauterine device
    Helen Paterson
    Department of Women s and Child Health, University of Otago, Dunedin 9054, New Zealand
    Contraception 76:306-9. 2007
  4. doi request reprint Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study
    Mira Harrison-Woolrych
    Intensive Medicines Monitoring Programme, New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago Medical School, Dunedin, New Zealand
    Pharmacoepidemiol Drug Saf 22:1086-92. 2013
  5. ncbi request reprint Weight and height measurement: potential impact in obstetric care
    Emma Jeffs
    Department of Women s and Children s Health, Dunedin School of Medicine, University of Otago, PO Box 913 Dunedin, New Zealand
    N Z Med J 127:17-26. 2014

Collaborators

Detail Information

Publications5

  1. doi request reprint A survey of New Zealand RANZCOG Fellows on their use of the levonorgestrel intrauterine device in adolescents
    Helen Paterson
    Department of Women s and Children s Health, University of Otago, Dunedin, New Zealand
    Aust N Z J Obstet Gynaecol 49:220-5. 2009
    ..Although it is being used in adolescents, there is little published research in this age group to date. Recent reviews and editorials have challenged the long-held views that intrauterine devices should not be used in young women...
  2. doi request reprint A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents
    Helen Paterson
    Dunedin School of Medicine, Department of Women s and Children s Health, University of Otago Dunedin, New Zealand
    Contraception 79:433-8. 2009
    ..While the use of the levonorgestrel intrauterine device (LNG-IUD) is well established in the adult population, there have been no research studies specifically on the use of the LNG-IUD in adolescents...
  3. ncbi request reprint Hair loss with use of the levonorgestrel intrauterine device
    Helen Paterson
    Department of Women s and Child Health, University of Otago, Dunedin 9054, New Zealand
    Contraception 76:306-9. 2007
    ..The levonorgestrel intrauterine device (IUD) has associated systemic side effects. However, there is little published information about the risk of alopecia...
  4. doi request reprint Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study
    Mira Harrison-Woolrych
    Intensive Medicines Monitoring Programme, New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago Medical School, Dunedin, New Zealand
    Pharmacoepidemiol Drug Saf 22:1086-92. 2013
    ..The purpose of this study was to investigate the extent of exposure to varenicline during pregnancy in 'real-life' post-marketing use and follow-up all pregnancy exposures to identify maternal and fetal outcomes...
  5. ncbi request reprint Weight and height measurement: potential impact in obstetric care
    Emma Jeffs
    Department of Women s and Children s Health, Dunedin School of Medicine, University of Otago, PO Box 913 Dunedin, New Zealand
    N Z Med J 127:17-26. 2014
    ..To assess the accuracy of reported weight and height in a pregnant population...